Oksi J, Aalto A, Saila P, Partanen T, et al. Real-world efficacy of bezlotoxumab for prevention of recurrent Clostridium difficile infection: a retrospective study of 46 patients in five university hospitals in Finland. Eur J Clin Microbiol Infect Dis 2019;38:1947-1952.
PMID: 31359254